Phospho-SMAD3 (S208) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Phospho-SMAD3 (S208) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPhospho-SMAD3 (S208)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman (predicted reactivity: chicken, mouse, porcine, rat)
Isotypen/a
Formatpeptide affinity purified
Size0.08 mL, 0.4 mL
Concentrationvial concentration: 0.5
ApplicationsImmunofluorescence (IF), Dot Blot (DB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis SMAD3 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S208 of human SMAD3. SMAD3, a receptor regulated SMAD (R-SMAD) is a transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinase. SMAD3 is estimated to account for at least 80% of all TGF-beta-mediated response. Activated type I receptor phosphorylates receptor-activated SMADS (RSMADS) at their c-terminal two extreme serines in the SSXS motif. The phosphorylated R-SMAD translocate into nucleus, where they regulate transcription of target genes. SMAD3 signal transduction appears to be important in the rgulation of muscle-specific genes. Loss
Immunogenn/a
Other Names[Mothers against decapentaplegic homolog 3; MAD homolog 3; Mad3; Mothers against DPP homolog 3; hMAD-3; JV15-2; SMAD family member 3; SMAD 3; Smad3; hSMAD3; SMAD3; MADH3]
Gene, Accession #[SMAD3], Gene ID: 4088, NCBI: NP_001138574.1, UniProt: P84022
Catalog #MBS9213657
Price$165, $370
Order / More InfoPhospho-SMAD3 (S208) Antibody from MYBIOSOURCE INC.
Product Specific ReferencesReferences for protein: 1.Imoto, S., et al., FEBS Lett. 579(13):2853-2862 (2005). 2.Dubrovska, A., et al., Oncogene 24(14):2289-2297 (2005). 3.Furumatsu, T., et al., J. Biol. Chem. 280(9):8343-8350 (2005). 4.Kobayashi, T., et al., Biochem. Biophys. Res. Commun. 327(2):393-398 (2005). 5.Kamaraju, A.K., et al., J. Biol. Chem. 280(2):1024-1036 (2005). References for HeLa cell line: 1. Scherer WF, Syverton JT, Gey GO (May 1953). Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J. Exp. Med. 97 (5): 695-710. [PubMed:13052828]. 2. Macville M, Schrock E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, Popescu N, Ried T (January 1999). Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 59 (1): 141-50. [PubMed: 9892199]. 3. Rahbari R, Sheahan T, Modes V, Collier P, Macfarlane C, Badge RM (April 2009). A novel L1 retrotransposon marker for HeLa cell line identification. BioTechniques 46 (4): 277-84. [PubMed: 19450234]. 4. Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA, Reddel RR, Freshney RI (July 2010). Check your cultures. A list of cross-contaminated or misidentified cell lines. Int. J. Cancer 127 (1): 1-8. [PubMed:20143388].
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.